Medicare Enrolled
Dr. Kenneth Sha, M.D.
Pulmonary Disease · Flushing, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sha?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sha
Dr. Kenneth Sha is a pulmonary disease specialist in Flushing, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sha performed 1,448 Medicare services across 1,056 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sha received a total of $24,624 from 46 pharmaceutical and/or device companies across 1105 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sha is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 29% volume in NY
$24,624 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,448
Medicare services
Top 29% in NY for pulmonary disease
1,056
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~72 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
589 | $79 | $150 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
251 | $35 | $180 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
152 | $40 | $100 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
151 | $54 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
72 | $114 | $239 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
53 | $100 | $200 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
26 | $67 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $142 | $310 |
| Vaccine administration The process of giving a vaccine to a patient. This code covers the administration service only and does not include the cost of the vaccine itself. |
24 | $17 | $65 |
| Venipuncture for blood draw Insertion of a needle into a vein to collect blood samples. This procedure is performed on patients aged 3 years or older. |
23 | $15 | $40 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
20 | $33 | $60 |
| Annual depression screening | 19 | $22 | $23 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
18 | $28 | $239 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
14 | $580 | $1,500 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
11 | $143 | $209 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$24,624
Total received (2018-2024)
Avg $3,518/year across 7 years
Top 10% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
1,105
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,624 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,778
2023
$4,101
2022
$3,937
2021
$4,028
2020
$2,414
2019
$3,503
2018
$2,864
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$664
GlaxoSmithKline, LLC.
$545
Mallinckrodt Hospital Products Inc.
$529
Boehringer Ingelheim Pharmaceuticals, Inc.
$367
Regeneron Healthcare Solutions, Inc.
$311
Insmed, Inc.
$304
Amgen Inc.
$209
Baxter Healthcare
$156
Electromed, Inc.
$152
Actelion Pharmaceuticals US, Inc.
$139
Philips North America LLC
$103
Mylan Specialty L.P.
$69
GENZYME CORPORATION
$68
Takeda Pharmaceuticals U.S.A., Inc.
$66
Phathom Pharmaceuticals, Inc.
$51
Merck Sharp & Dohme LLC
$25
Genentech USA, Inc.
$21
Top 3 companies account for 46.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$3,974
Boehringer Ingelheim Pharmaceuticals, Inc.
$3,755
AstraZeneca Pharmaceuticals LP
$2,739
Mallinckrodt Hospital Products Inc.
$2,429
Regeneron Healthcare Solutions, Inc.
$1,509
Actelion Pharmaceuticals US, Inc.
$1,205
Insmed, Inc.
$1,156
Genentech USA, Inc.
$872
Electromed, Inc.
$763
Amgen Inc.
$599
Mylan Specialty L.P.
$593
Sunovion Pharmaceuticals Inc.
$581
Philips Electronics North America Corporation
$545
Baxter Healthcare
$404
Novo Nordisk Inc
$342
Mallinckrodt Enterprises LLC
$330
Teva Pharmaceuticals USA, Inc.
$321
Advanced Respiratory, Inc
$315
Takeda Pharmaceuticals U.S.A., Inc.
$208
Lilly USA, LLC
$200
AbbVie Inc.
$175
United Therapeutics Corporation
$158
OptiNose US, Inc.
$124
ANI Pharmaceuticals, Inc.
$117
Philips North America LLC
$103
Circassia Pharmaceuticals Inc
$99
GENZYME CORPORATION
$93
PFIZER INC.
$88
Janssen Pharmaceuticals, Inc
$82
Shire North American Group Inc
$81
Bayer HealthCare Pharmaceuticals Inc.
$80
ABBVIE INC.
$78
Merck Sharp & Dohme LLC
$71
Merck Sharp & Dohme Corporation
$58
ADVANCED RESPIRATORY, INC
$55
Phathom Pharmaceuticals, Inc.
$51
Inogen, Inc.
$44
JAZZ PHARMACEUTICALS INC.
$44
Melinta Therapeutics, LLC
$40
Mallinckrodt LLC
$34
Jazz Pharmaceuticals Inc.
$24
Grifols USA, LLC
$21
Kowa Pharmaceuticals America, Inc.
$20
Gilead Sciences, Inc.
$17
Hikma Pharmaceuticals USA
$16
E.R. Squibb & Sons, L.L.C.
$12
Top 3 companies account for 42.5% of all-time payments
Associated products mentioned in payments ›
(2535) Sleep Service · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · Adempas · AirDuo Digihaler · Arikayce · ArmonAir Digihaler · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · Baxdela · CHANTIX · CINQAIR · CREON · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DreamWear · DreamWear Pillows · ELIQUIS · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · InogenOne · JARDIANCE · KEYTRUDA · KRYSTEXXA · LINZESS · LONHALA MAGNAIR · Letairis · Life 2000 Ventilation System · Livalo · MOUNJARO · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Ozempic · PREVNAR - 13 · PURIFIED CORTROPHIN GEL · Prolastin-C · QVAR · Respiratoriy Care Undiv · Ryaltris · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TAGRISSO · TAVNEOS · TEZSPIRE · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TYVASO · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · Tresiba · Trilogy 100 · UPTRAVI · UTIBRON · Utibron · VOQUEZNA · Verquvo · Victoza · Wellcentive Undiv · XARELTO · Xhance · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for pulmonary disease in NY.
Geographic Context
Pulmonary diseases within 10 mi
659
Per 100K population
28.3
County median income
$84,961
Nearest hospital
NEW YORK-PRESBYTERIAN/QUEENS
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sha is a clinical cardiology specialist, with above-average Medicare volume (top 29% in NY), with low-engagement industry engagement in the top 10% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sha experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Sha performed 589 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sha receive payments from pharmaceutical companies?
Yes. Dr. Sha received a total of $24,624 from 46 companies across 1,105 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sha's costs compare to other pulmonary diseases in Flushing?
Dr. Sha's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Flushing
Browse pulmonary diseases in Flushing ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology